A61K 47/26
Carbohydrates
Official title: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K47/26 (Carbohydrates) appears on 6,795 US grants and 13,112 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,795
- Published applications
- 13,112
- Assignees
- 4,615
- Inventors
- 20,997
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 5 | 0 |
| 1978 | 8 | 0 |
| 1979 | 9 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 14 | 0 |
| 1985 | 8 | 0 |
| 1986 | 11 | 0 |
| 1987 | 11 | 0 |
| 1988 | 5 | 0 |
| 1989 | 24 | 0 |
| 1990 | 19 | 0 |
| 1991 | 16 | 0 |
| 1992 | 21 | 0 |
| 1993 | 28 | 0 |
| 1994 | 22 | 0 |
| 1995 | 37 | 0 |
| 1996 | 56 | 0 |
| 1997 | 86 | 0 |
| 1998 | 50 | 0 |
| 1999 | 78 | 0 |
| 2000 | 48 | 0 |
| 2001 | 66 | 25 |
| 2002 | 44 | 87 |
| 2003 | 45 | 140 |
| 2004 | 48 | 161 |
| 2005 | 31 | 168 |
| 2006 | 69 | 182 |
| 2007 | 50 | 184 |
| 2008 | 39 | 214 |
| 2009 | 51 | 236 |
| 2010 | 104 | 249 |
| 2011 | 101 | 269 |
| 2012 | 142 | 301 |
| 2013 | 167 | 365 |
| 2014 | 233 | 485 |
| 2015 | 256 | 576 |
| 2016 | 338 | 657 |
| 2017 | 357 | 717 |
| 2018 | 380 | 664 |
| 2019 | 378 | 782 |
| 2020 | 464 | 891 |
| 2021 | 468 | 1022 |
| 2022 | 503 | 992 |
| 2023 | 472 | 1048 |
| 2024 | 506 | 996 |
| 2025 | 556 | 886 |
| 2026 | 346 | 815 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Medication that protects the intestinal microbiota and their preparation methods and applications6 Oct 2026US 12,751,921 B2University of Science and Technology of China
- Stable levothyroxine compositions in aprotic polar solvents6 Oct 2026US 12,751,937 B2Xeris Pharmaceuticals, Inc.
- Topical ocular delivery of cromakalim6 Oct 2026US 12,751,939 B2Mayo Foundtation for Medical Education and Research
- Topical anaesthetic composition having improved vasoconstrictor stability6 Oct 2026US 12,751,946 B2Animal Ethics Pty Ltd
- Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof6 Oct 2026US 12,753,170 B2Akagera Medicines, Inc.
- Suspension containing heterocyclidene acetamide derivative8 Oct 2026US 2026/0306401 A1Mochida Pharmaceutical Co., Ltd.
- Compositions for the effective treatment of vitamin c deficiency-related diseases and other conditions8 Oct 2026US 2026/0306447 A1
- Amlodipine formulations8 Oct 2026US 2026/0306467 A1Azurity Pharmaceuticals, Inc.
- Polymorphic forms and formulations of leriglitazone8 Oct 2026US 2026/0306468 A1Minoryx Therapeutics S.L.
- Liquid and solid compositions of imipridone derivatives8 Oct 2026US 2026/0306494 A1Assistance Publique-Hopitaux de Paris
Most cited
By later US patents
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992
- High viscosity liquid controlled delivery system354US 5,747,058 ASouthern BioSystems, Inc. · 1998
- Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1328US 7,595,048 B2Ono Pharmaceutical Co., Ltd. · 2009
- Human antibodies that bind human IL-12 and methods for producing300US 6,914,128 B1Abbott GmbH & Co. KG · 2005
- Emulsion compositions271US 7,622,280 B2454 Life Sciences Corporation · 2009